levomethadone (Lynda Therapeutics/NIH)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namelevomethadone (Lynda Therapeutics/NIH)
Drug Alias Namelevomethadone (Lyndra Therapeutics/NIH)levomethadoneLYN-014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsOpioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLyndra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLyndra Therapeutics IncNational Institutes Of Health
Inactive CompaniesN/A
Active IndicationsOpioid-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A